Abstract Title:

Anti-fibrotic cardioprotection of berberine via down-regulating myocardial IGF-1 receptor-regulated MMP-2/9 expression in diabetic rats.

Abstract Source:

Am J Physiol Heart Circ Physiol. 2018 Jun 29. Epub 2018 Jun 29. PMID: 29957017

Abstract Author(s):

Guohua Li, Wenjuan Xing, Min Zhang, Feng-Hao Geng, Hongyan Yang, Haifeng Zhang, Xing Zhang, Jia Li, Ling Dong, Feng Gao

Article Affiliation:

Guohua Li


Diabetic cardiac fibrosis increases ventricular stiffness and facilitates occurrence of diastolic dysfunction. Our previous studies have shown that berberine, a natural alkaloid, attenuates cardiac ischemic/reperfusion injury in diabetic rats. The aim of present study was to investigate the effects of long-term berberine treatment on cardiac remodeling in diabetic rats and the underlying mechanisms. Diabetic rats induced by low dose of streptozotocin injection combined with 8-week high-fat diet displayed significant cardiac matrix collagen deposition and dysfunction, while berberine administration (200 mg•kg•day, gavage, 4 weeks) significantly ameliorated cardiac fibrosis and dysfunction and reduced cardiac IGF-1 receptor (IGF-1R) expression in diabetic rats. Interestingly, IGF-1R expression was up-regulated in cardiac fibroblasts isolated from diabetic hearts or cultured in high glucose condition (30 mM). High glucose treatment or IGF-1R overexpression increased matrix metalloproteinase (MMP)-2/9 expression,α-smooth muscle actin (α-SMA) and collagen I expression in cardiac fibroblasts. In contrast, berberine treatment significantly inhibited IGF-1R expression and exerted an anti-fibrotic effect in high glucose-cultured cardiac fibroblasts, as manifested by decreased MMP-2/9, a-SMA and collagen I expression, while IGF-1R siRNA plus berberine treatment did not further enhance this anti-fibrotic effect compared with berberine treatment alone. Taken together, long-term berberine treatment ameliorates cardiac fibrosis and dysfunction by down-regulating IGF-1R expression in cardiac fibroblasts, and subsequently reducing MMP-2/9, a-SMA and collagen I expression in diabetic hearts. The findings suggest berberine's therapeutic potential for diabetic cardiomyopathy associated with cardiac fibrosis.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.